| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.81▼ | 4.75▲ | 4.72▲ | 4.64▲ | 4.59▲ |
| MA10 | 4.79▼ | 4.67▲ | 4.66▲ | 4.67▲ | 4.41▲ |
| MA20 | 4.75▲ | 4.64▲ | 4.62▲ | 4.64▲ | 4.20▲ |
| MA50 | 4.67▲ | 4.58▲ | 4.65▲ | 4.43▲ | 5.27▼ |
| MA100 | 4.64▲ | 4.65▲ | 4.63▲ | 4.13▲ | N/A |
| MA200 | 4.60▲ | 4.62▲ | 4.48▲ | 4.64▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.022▲ | 0.028▲ | -0.010▼ | 0.191▲ |
| RSI | 62.758▲ | 64.255▲ | 61.868▲ | 57.388▲ | 51.503▲ |
| STOCH | 81.148▲ | 93.962▲ | 78.470 | 53.684 | 59.713 |
| WILL %R | -44.000 | -16.667▲ | -15.942▲ | -18.627▲ | -25.237 |
| CCI | 47.722 | 149.400▲ | 189.072▲ | 55.340 | 66.608 |
|
Tuesday, November 04, 2025 05:16 AM
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with ...
|
|
Monday, October 20, 2025 11:25 PM
NovaBay Pharmaceuticals (NYSE:NBY) has formally regained compliance with the NYSE American's continued listing standards, successfully resolving deficiencies first cited in April and May 2024. The ...
|
|
Monday, October 20, 2025 07:24 PM
NovaBay (NBY) Pharmaceuticals announced that it has regained compliance with the NYSE American’s continued listing standards. As previously disclosed, the NYSE American notified the company on April ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/11/25 | 4.57 | 4.84 | 4.51 | 4.785 | 716,151 |
| 05/11/25 | 4.57 | 4.71 | 4.52 | 4.57 | 222,070 |
| 04/11/25 | 4.44 | 4.65 | 4.41 | 4.55 | 788,577 |
| 03/11/25 | 4.71 | 4.75 | 4.385 | 4.56 | 843,730 |
| 31/10/25 | 4.65 | 4.80 | 4.63 | 4.75 | 330,005 |
| 30/10/25 | 4.68 | 4.81 | 4.61 | 4.66 | 309,182 |
| 29/10/25 | 4.81 | 4.85 | 4.64 | 4.71 | 586,723 |
| 28/10/25 | 4.77 | 4.88 | 4.645 | 4.81 | 409,121 |
| 27/10/25 | 4.51 | 4.81 | 4.51 | 4.81 | 448,009 |
| 24/10/25 | 4.62 | 4.72 | 4.50 | 4.51 | 352,914 |
|
|
||||
|
|
||||
|
|